Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes

Kidney International

Volumn 68, Issue 4, 2005, Pages 1722-1728

  Cherney, David Z I ^b   Sochett, Etienne B ^b   Miller, Judith A ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Gender; Glomerular filtration rate; Hyperfiltration state; Renin angiotensin system; Type 1 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; ENZYME INHIBITION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; HYPERTENSION, RENAL; KIDNEY; RENAL CIRCULATION; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 31644442758     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00588.x     Document Type: Article

References (42)

1. MANGILI R, DEFERRARI G, DI MARIO U, et al, FOR THE ITALIAN MICROALBUMINURIA STUDY GROUP: Arterial hypertension and microalbuminuria in IDDM: The Italian Microalbuminuria Study. Diabetologia 37:1015-1024, 1994
2. ORCHARD TJ, DORMAN JS, MASER RE, et al: Prevalence of complications of IDDM by sex and duration. Diabetes 39:1116-1124, 1990
3. JACOBSEN P, ROSSING K, TARNOW L, et al: Progression of diabetic nephropathy in normotensive type I diabetes patients. Kidney Int 56 (Suppl 71): S101-S105, 1999
4. BREYER JA, BAIN RP, EVANS JK, et al: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
5. COONROD BA, ELLIS D, BECKER DJ, et al: Predictors of microalbuminuria in individuals with IDDM. Diabetes Care 16:1376-1383, 1993
6. MUHLHAUSER I, BENDER R, BOTT U, et al: Cigarette smoking and progression of retinopathy and nephropathy in type I diabetes. Diab Med 13:536-543, 1996
7. MOGENSEN CE: Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scan J Clin Invest 46:201-206, 1986
8. PECIS M, AZEVEDO MJ, GROSS JL: Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 20:1329-1333, 1997
9. PRICE DA, PORTER LE, GORDON M, et al: The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10:2382-2391, 1999
10. MILLER JA: Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10:1778-1785, 1999
11. CHIDAMBARAM M, DUNCAN JA, LAI VS, et al: Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13:446-452, 2002
12. LANSANG MC, HOLLENBERG NK: Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: Are the forces leading to vasodilation and vasoconstriction linked? Diabetes 51:2025-2028, 2002
13. MARRE M, BOUHANICK B, BERRUT G, et al: Renal changes on hyperglycemia and angiotensin-cnverting enzyme in type 1 diabetes. Hypertension 33:775-780, 1999
14. HOLLENBERG NK, PRICE DA, FISHER NDL, et al: Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int 63:172-178, 2003
15. ANDERSON S, VORA JT: Current concepts of renal hemodynamics in diabetes. J Diab Complic 9:304-307, 1995
16. SCHNURR E, LAHME W, KUPPERS H: Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 13:26-29, 1980.
17. CUMMINGS EA, SOCHETT EB, DEKKER MG, et al: Contribution of growth hormone and IGF1 to early diabetic nephropathy in type 1 diabetes. Diabetes 47:1341-1346, 1998
18. GORMAN D, SOCHETT EB, DANEMAN D: The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr 134:333-337, 1999
19. MUNGER K, BAYLIS C: Sex differences in renal hemodynamics in rats. Am J Physiol 254:F223-F231, 1998
20. BAYLIS C, WILSON CB. Sex and the single kidney. Am J Kidney Dis 13:290-298, 1989
21. SMITH HW: The Kidney, Structure and Function in Health and Disease, New York, NY, Oxford University Press, 1951
22. SLACK TK, WILSON DM: Normal renal function. Cin and CPAH in healthy donors before and after nephrectomy. Mayo Clin Proc 51:296-300, 1976
23. WESSON LG: Renal hemodynamics in physiological states, in The Physiology of the Human Kidney, edited by Wesson JG, New York, NY, Grune and Stratton, 1969
24. O'BRYAN GT, HOSTETTER TH: The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17:93-100, 1997
25. RECKELHOFF JF: Gender differences in the regulation of blood pressure. Hypertension 37:1199-1208, 2001
26. HARSHFIELD GA, ALPERT BS, PULLIAM DA, et al: Ambulatory blood pressure recordings in children and adolescents. Pediatrics 94:180-184, 1994
27. NEUGARTEN J, ACHARYA A, SILBIGER S: Effect of gender on the progression of non-diabetic kidney disease: a meta-analysis. J Am Soc Nephrol 11:319-329, 2001
28. ANDERSON S, RENNKE H, BRENNER B: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
29. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
30. ROSENBERG ME, SMITH LJ, CORREA-ROTTER R, HOSTETTER TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
31. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
32. GALLAGHER PE, LI P, LENHART JR, et al: Estrogen regulation of angiotensin concerting enzyme mRNA. Hypertension 33:323-328, 1999
33. BROSNIHAN KB, LI P, GANTEN D, MERRARIO CM: Estrogen protects transgenic rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol 273:R1908-R1915, 1997
34. MILLER JA, ANACTA LA, CATTRAN DC: Impact of gender on the renal response to angiotensin II. Kidney Int 55:278-285, 1999
35. CHAPMAN AB, ZAMUDIO S, WOODMANSEE W, et al: Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 273:F777-F782, 1997
36. RUGGENENTI P, PERNA A, ZOCCALI C, et al: Chronic proteinuric nephropathies. II. Outcomes and responses to treatment in a prospective cohort of 352 patients: differences between men and women in relation to ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 11:88-96, 2000
37. SZEKACS B, VAJO Z, VARBIRO S, et al: Postmenopausal hormone replacement therapy improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension. BJOG 107:1017-1021, 2000
38. MANKHEY RW, BHATTI F, MARIC C: 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288:F399-F405, 2005
39. LIU HW, IWAI M, TAKEDA-MATSUBARA Y, et al: Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 40:451-457, 2002
40. SELIGER SL, DAVID C, STEHMAN-BREEN C. Gender and the progression of kidney disease. Curr Opin Nephrol Hypertens 10:219-255, 2001
41. BURNIER M, NUSSBERGER J, BIOLLAZ J, et al: Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 22:339-347, 1993
42. KANG AK, DUNCAN JA, CATTRAN DC, et al: Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 280:R807-R813, 2001